Institutional Members

Become an Institutional Member

To learn more about becoming an Institutional Member of the Human Variome Project, or to see Insitutional Members benefits, please click here.

Current Institutional Members

The RCPA is the leading organisation representing Pathologists and Senior Scientists in Australasia. Its mission is to train and support pathologists and to improve the use of pathology testing to achieve better healthcare. For those who are not already familiar with this area of medicine, pathology is about the study of the causes of disease and pathologists are the specialist medical doctors involved in the diagnosis and monitoring almost of all acute and chronic illnesses.

As a way of background, the College was first established in 1956 and has been responsible for the training and professional development of Pathologists since that time and more recently Senior Scientists. College members come from across Australasia including Australia, New Zealand, Hong Kong, Singapore, Malaysia and Saudi Arabia. The RCPA is also responsible for the promotion of the science and practice of pathology.

The RCPA offices are located in the heritage listed, Durham Hall in Surry Hills, Sydney. It is a not-for-profit organisation which is governed by its Board of Directors. The College’s current President is Dr Michael Harrison and its CEO is Dr Debra Graves. The College management team consists of some 40 staff members who administer all aspects of the running of the College.

The various areas of this site cover: the College structure and its committees; training requirements for a career in pathology and the various disciplines of pathology on offer; and College publications and pathology in the news. It also provides information about continuing education, major events, College policies, documents and publications.

The Garvan Institute of Medical Research is one of Australia’s leading medical research institutes, based in Sydney. It is affiliated with St Vincent’s Hospital and the University of New South Wales. It has six research Divisions: Cancer, Genomics & Epigenomics, Diabetes & Metabolism, Immunology, Neuroscience, and Bone Biology. Its mission is to advance medical knowledge and healthcare by fundamental discovery and active translation into clinical practice. The Garvan Institute is home to the Kinghorn Centre for Clinical Genomics (KCCG), Australia’s only provider of population-scale whole genome sequencing (WGS). KCCG was one of the first centres in the world to acquire the Illumina HiSeq X Ten system, capable of sequencing up to 18,000 human genomes per annum. In 2016 KCCG is expected to sequence over 10,000 genomes for research and clinical purposes. The KCCG is staffed by a growing team of over 40 medical geneticists, molecular pathologists, genome scientists, bioinformaticians, technical specialists, software engineers, database curators and research students. The diagnostic pipeline developed at the KCCG focuses on the intersection of genotype and phenotype, adhering to the principles of responsible molecular interpretation set out by the American College of Medical Genetics. The KCCG is working to increase high quality genomic knowledge through the development of sophisticated and scalable analytical software, and through the construction and curation of genotype-phenotype databases, for the identification of novel genes and pathogenic variants associated with Mendelian disorders and cancer, with the aim of expanding genome sequencing and variome analysis to the entire consenting population, as the basis for understanding human biology and diversity, and the transformation of healthcare.

UQ Research

One of Australia’s premier research and teaching institutions, UQ has made significant contributions to knowledge and society through its unrelenting pursuit of academic excellence, innovative research, and contemporary social relevance. UQ’s research community excels, pioneering positive change to offer solutions to some of the great challenges of our time. UQ’s broad research capability includes life sciences, nanotechnology, eResearch, engineering, social sciences and humanities.

About UQ Genomics

The University of Queensland (UQ) is a key player in global genomics research, accommodating the largest and most sophisticated genomics capability in southern hemisphere. Established as a virtual network, the UQ Genomics Initiative aims to facilitate partnerships and engagement across all genomics researchers at UQ’s many institutes, faculties, and centres, to form an integrated research alliance.

It also aims to foster effective and productive collaborations with Queensland’s leading healthcare providers, universities and other research organisations to harness Queensland’s clinical, research and education strengths and translating multidisciplinary knowledge into beneficial, practical outcomes.

Queensland Genomics Health Alliance

On the 22nd of September 2015, the Queensland State Government announces a $25m five-year commitment to research aimed at integrating genomics into everyday healthcare.

Potentially positioning Queensland as a world-leader in the translation of genomics research into healthcare practice, the Queensland Genomics Health Alliance (QGHA) will encourage collaboration within and between the state's health system and research and academic communities to discover how genomics can improve health outcomes for Queenslanders.

With a charter to be patient-centered and clinically-led, the University of Queensland has been chosen to lead the QGHA, working collaboratively with all universities in the State, key Queensland-based research organisations, the Queensland Hospital and Health Services network, private health care providers and associated health care organisations throughout the State.

China National GeneBank (CNGB), as an unincorporated international collaborative institute, is devoted to the comprehensive collection of biological resources (including specimens from humans, and other animals, plants and microorganisms preservation), biological data generation global networkto promote information sharing and exchange. CNGB is developing a biobank consortium across China and a worldwide collaborative effort for samples and data sharing in multi-omics scientific research.

PrecisionMDX gives clinicians tools to better understand the complex mechanisms underlying a patient's health, disease, or condition, and to better predict which treatments will be most effective.

PrecisionMDx (PMD) is a company offers cutting edge genetic tests. We are committed to conducting research and analyzing genetic cause of human disease, such as birth defects, diabetes and tumor. PMD has built a clinical center equipped with tools to perform immunological and molecular tests. We have collected large number of biological samples and related data while we perform clinical tests. We believe we share same mission as HVP network, public data sharing, which will advance this field greatly and bringing further innovation of personalized medicine.